These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34850053)

  • 41. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss.
    Kim YH; Nonoguchi N; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Mariani L; Giangaspero F; Tanaka Y; Nakazato Y; Vital A; Mittelbronn M; Perry A; Ohgaki H
    Brain Pathol; 2012 Nov; 22(6):834-40. PubMed ID: 22568401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.
    Misove A; Vicha A; Broz P; Vanova K; Sumerauer D; Stolova L; Sramkova L; Koblizek M; Zamecnik J; Kyncl M; Holubova Z; Liby P; Taborsky J; Benes V; Pernikova I; Jones DTW; Sill M; Stancokova T; Krskova L; Zapotocky M
    Acta Neuropathol Commun; 2022 Sep; 10(1):143. PubMed ID: 36163281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling.
    Anastasaki C; Chatterjee J; Cobb O; Sanapala S; Scheaffer SM; De Andrade Costa A; Wilson AF; Kernan CM; Zafar AH; Ge X; Garbow JR; Rodriguez FJ; Gutmann DH
    Acta Neuropathol Commun; 2022 Aug; 10(1):120. PubMed ID: 35986378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.
    Lo HW
    Curr Cancer Drug Targets; 2010 Dec; 10(8):840-8. PubMed ID: 20718706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular and clinicopathologic features of gliomas harboring NTRK fusions.
    Torre M; Vasudevaraja V; Serrano J; DeLorenzo M; Malinowski S; Blandin AF; Pages M; Ligon AH; Dong F; Meredith DM; Nasrallah MP; Horbinski C; Dahiya S; Ligon KL; Santi M; Ramkissoon SH; Filbin MG; Snuderl M; Alexandrescu S
    Acta Neuropathol Commun; 2020 Jul; 8(1):107. PubMed ID: 32665022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of the KIAA1549-BRAF fusion gene in cells forming microvascular proliferations in pilocytic astrocytoma.
    Yamashita S; Takeshima H; Matsumoto F; Yamasaki K; Fukushima T; Sakoda H; Nakazato M; Saito K; Mizuguchi A; Watanabe T; Ohta H; Yokogami K
    PLoS One; 2019; 14(7):e0220146. PubMed ID: 31329636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology.
    Lawson AR; Hindley GF; Forshew T; Tatevossian RG; Jamie GA; Kelly GP; Neale GA; Ma J; Jones TA; Ellison DW; Sheer D
    Genome Res; 2011 Apr; 21(4):505-14. PubMed ID: 21393386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
    Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.
    Pfister S; Janzarik WG; Remke M; Ernst A; Werft W; Becker N; Toedt G; Wittmann A; Kratz C; Olbrich H; Ahmadi R; Thieme B; Joos S; Radlwimmer B; Kulozik A; Pietsch T; Herold-Mende C; Gnekow A; Reifenberger G; Korshunov A; Scheurlen W; Omran H; Lichter P
    J Clin Invest; 2008 May; 118(5):1739-49. PubMed ID: 18398503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    Ishi Y; Yamaguchi S; Hatanaka KC; Okamoto M; Motegi H; Kobayashi H; Terasaka S; Houkin K
    J Neurosurg; 2021 Mar; 134(3):733-741. PubMed ID: 32059187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
    Rankin A; Johnson A; Roos A; Kannan G; Knipstein J; Britt N; Rosenzweig M; Haberberger J; Pavlick D; Severson E; Vergilio JA; Squillace R; Erlich R; Sathyan P; Cramer S; Kram D; Ross J; Miller V; Reddy P; Alexander B; Ali SM; Ramkissoon S
    Oncologist; 2021 Jan; 26(1):e153-e163. PubMed ID: 32918774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data.
    Stichel D; Schrimpf D; Sievers P; Reinhardt A; Suwala AK; Sill M; Reuss DE; Korshunov A; Casalini BM; Sommerkamp AC; Ecker J; Selt F; Sturm D; Gnekow A; Koch A; Simon M; Hernáiz Driever P; Schüller U; Capper D; van Tilburg CM; Witt O; Milde T; Pfister SM; Jones DTW; von Deimling A; Sahm F; Wefers AK
    Neuropathol Appl Neurobiol; 2021 Apr; 47(3):406-414. PubMed ID: 33336421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
    Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
    Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.
    Milde T; Rodriguez FJ; Barnholtz-Sloan JS; Patil N; Eberhart CG; Gutmann DH
    Neuro Oncol; 2021 Oct; 23(10):1634-1646. PubMed ID: 34131743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rare adult pilocytic astrocytoma of the septum pellucidum with novel RIN2::BRAF fusion.
    Liu X; Dai X; Dai C; Zhu Q; Chen A; Chen Y; Chen N; Chen P; Rong R; Shi C; Xiao S; Dong J
    Virchows Arch; 2023 Feb; 482(2):445-450. PubMed ID: 36520196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
    Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.